First Horizon Advisors Inc. Buys 370 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

First Horizon Advisors Inc. increased its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 82.6% during the third quarter, HoldingsChannel.com reports. The firm owned 818 shares of the technology company’s stock after buying an additional 370 shares during the period. First Horizon Advisors Inc.’s holdings in Simulations Plus were worth $26,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in Simulations Plus by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 1,135,105 shares of the technology company’s stock valued at $46,710,000 after purchasing an additional 12,636 shares during the period. Price T Rowe Associates Inc. MD grew its position in Simulations Plus by 5.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 10,048 shares of the technology company’s stock worth $414,000 after buying an additional 562 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in Simulations Plus in the 1st quarter worth about $1,082,000. Silvercrest Asset Management Group LLC purchased a new stake in shares of Simulations Plus in the 1st quarter valued at about $4,717,000. Finally, SG Americas Securities LLC bought a new stake in shares of Simulations Plus during the 2nd quarter valued at about $1,320,000. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $31.26, for a total value of $625,200.00. Following the sale, the director now directly owns 3,481,592 shares of the company’s stock, valued at $108,834,565.92. This trade represents a 0.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold 60,750 shares of company stock worth $1,905,655 in the last three months. 20.90% of the stock is owned by insiders.

Simulations Plus Trading Up 4.5 %

Shares of NASDAQ:SLP opened at $32.74 on Tuesday. The stock has a market capitalization of $656.99 million, a P/E ratio of 66.82 and a beta of 0.71. The stock’s 50-day moving average price is $30.80 and its 200-day moving average price is $38.17. Simulations Plus, Inc. has a 12-month low of $27.07 and a 12-month high of $51.22.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The business had revenue of $18.70 million for the quarter, compared to analysts’ expectations of $19.73 million. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The business’s quarterly revenue was up 19.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.18 EPS. As a group, research analysts predict that Simulations Plus, Inc. will post 1.12 EPS for the current year.

Analyst Ratings Changes

SLP has been the topic of several research analyst reports. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, November 6th. BTIG Research lowered their price objective on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. StockNews.com lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. KeyCorp assumed coverage on Simulations Plus in a research note on Monday, July 29th. They set an “overweight” rating and a $47.00 price target for the company. Finally, Stephens began coverage on Simulations Plus in a research report on Friday, November 15th. They set an “overweight” rating and a $39.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $51.40.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.